Literature DB >> 7365506

Neurophysiological study of subacute combined degeneration.

E J Fine, M Hallett.   

Abstract

Three patients with subacute combined degeneration of the spinal cord due to vitamin B12 deficiency showed a characteristic pattern of abnormalities on neurophysiological tests which corresponded to the clinical signs and symptoms. Peripheral nerve conduction studies showed an axonal degeneration peripheral neuropathy. Brain stem auditory evoked responses were normal; visual evoked responses were mildly abnormal and somatosensory evoked responses were moderately abnormal. These studies shed light on the pathology of this disorder and can aid in its diagnosis.

Entities:  

Mesh:

Year:  1980        PMID: 7365506     DOI: 10.1016/0022-510x(80)90176-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Delayed somatosensory evoked potentials in pernicious anaemia with intact peripheral nerves.

Authors:  G D Perkin; S W Roche; R Abraham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

2.  Delayed somatosensory evoked potentials in pernicious anaemia with intact peripheral nerves.

Authors:  J P Dick; J C Smaje; P Crawford; R J Meara; D I Shepherd
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-08       Impact factor: 10.154

3.  Somatosensory cortical potentials evoked by stimulation of leg nerves: analysis of normal values and variability; diagnostic significance.

Authors:  P Vogel; H Vogel
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

4.  Neurological involvement in hereditary transcobalamin II deficiency.

Authors:  P K Thomas; A V Hoffbrand; I S Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-01       Impact factor: 10.154

5.  Feline irradiated diet-induced demyelination; a model of the neuropathology of sub-acute combined degeneration?

Authors:  Abigail B Radcliff; Moones Heidari; Aaron S Field; Ian D Duncan
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.